API2-MALT1chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years

This publication has 15 references indexed in Scilit:

• Clinicopathologic Comparison between the API2‐MALT1 Chimeric Transcript‐positive and ‐negative Gastric Low‐grade B‐Cell Lymphoma of Mucosa‐associated Lymphoid Tissue Type
  Japanese Journal of Cancer Research, 2002
• T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication
  Gastroenterology, 2002
• Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways
  Blood, 2002
• Helicobacter pyloriInfection and the Development of Gastric Cancer
  New England Journal of Medicine, 2001
• API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma
  Gastroenterology, 2001
• Incidence and Subtype Specificity of API2-MALT1 Fusion Translocations in Extranodal, Nodal, and Splenic Marginal Zone Lymphomas
  Published by Elsevier ,2000
• API2-MALT1 Chimeric Transcripts Involved in Mucosa-Associated Lymphoid Tissue Type Lymphoma Predict Heterogeneous Products
  The American Journal of Pathology, 2000
• Helicobacter pyloriand the t(11;18)(q21;q21) Translocation in Gastric Low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
  Japanese Journal of Cancer Research, 2000
• The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997
  Histopathology, 2000
• Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
  The Lancet, 1993